|
CLCN5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.9528046674443E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.23234755733392E-13 |
| Normal-vs-Stage2 |
3.052500E-02 |
| Normal-vs-Stage3 |
6.34450003644815E-09 |
| Normal-vs-Stage4 |
2.22460050380846E-10 |
| Stage1-vs-Stage2 |
4.747700E-02 |
| Stage1-vs-Stage3 |
9.189600E-01 |
| Stage1-vs-Stage4 |
5.276400E-01 |
| Stage2-vs-Stage3 |
7.429700E-02 |
| Stage2-vs-Stage4 |
2.846000E-02 |
| Stage3-vs-Stage4 |
5.270800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11100018074239E-12 |
| Normal-vs-AfricanAmerican |
9.037100E-04 |
| Normal-vs-Asian |
1.90759630314119E-11 |
| Caucasian-vs-AfricanAmerican |
1.836400E-01 |
| Caucasian-vs-Asian |
1.264550E-01 |
| AfricanAmerican-vs-Asian |
1.998020E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.17270004817982E-09 |
| Normal-vs-Female |
1.25550014828946E-10 |
| Male-vs-Female |
4.920000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.15707484996619E-12 |
| Normal-vs-Age(41-60Yrs) |
2.28040031302612E-10 |
| Normal-vs-Age(61-80Yrs) |
2.23739999999362E-05 |
| Normal-vs-Age(81-100Yrs) |
3.55899999999743E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.081800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.827900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.343200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.215900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.170180E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.399700E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.857700E-02 |
| Classical-VS-Follicular |
9.038900E-04 |
| Classical-VS-Other |
2.834800E-01 |
| Classical-VS-Normal |
1.70841119029319E-12 |
| Tall-VS-Follicular |
4.0448999999998E-05 |
| Tall-VS-Other |
4.512000E-01 |
| Tall-VS-Normal |
1.4915846335839E-12 |
| Follicular-VS-Other |
1.639730E-03 |
| Follicular-VS-Normal |
6.644100E-03 |
| Other-VS-Normal |
8.28000000000495E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.15430000002803E-08 |
| Normal-vs-N1 |
2.84616774592905E-12 |
| N0-vs-N1 |
1.312340E-02 |
|
|
